Revenue and Profit Growth Since Founding and Expansion of the Regenerative Medicine-Related Business
First written in FY2019. 15 of 28 entries say "Advanced", first in FY2020-Q1. Latest entry: 2026-09-09.
CellSource moved to the "Worse" side of this theme in 2024, 4 years after the typical company in this theme (2020).
The whole theme swung hardest in 2020: 29 of 142 companies on the "Worse" side.
86 other companies' latest entry also says "Other".
- FY2026-H1Profit recoveryAnnual report
「Operating income was ¥125.712 million, up 636.3% year on year, ordinary income was ¥115.671 million, up 510.4%, and interim net income attributable to owners of the parent was ¥71.190 million, up 537.2%.」
While net sales declined 2.5% year on year, operating income, ordinary income and interim net income all increased substantially from the previous year due to reductions in selling, general and administrative expenses. - FY2025WorsenedAnnual report
「During the consolidated fiscal year from 1 November 2024 to 31 October 2025, the number of contracts declined year on year for the company's main businesses, blood-derived processing contract services and adipose-derived stem cell processing contract services. Sales of medical devices, cosmetics and other products also fell below the previous fiscal year's results, contributing to the decline in net sales.」
The main processing contract services, medical device sales, and cosmetics and other sales fell below the previous fiscal year's results. On a standalone basis, net sales declined from ¥4,355.063 million to ¥3,602.955 million, resulting in a net loss of ¥18.765 million. - FY2025-H1WorsenedAnnual report
「During the interim consolidated accounting period, the number of contracts declined year on year for the company's main businesses, blood-derived processing contract services and adipose-derived stem cell processing contract services.」
The number of contracts for the main blood-derived and adipose-derived stem cell processing contract services declined year on year. During the interim consolidated accounting period, net sales were ¥1,820.503 million and operating income was ¥17.073 million, but no comparison with the previous interim consolidated accounting period was made because this was the first year of consolidation. - FY2024-Q2WorsenedAnnual report
「As a result, for the cumulative second quarter, net sales were ¥2,227.673 million, up 2.6% year on year, gross profit was ¥1,424.890 million, down 7.6%, selling, general and administrative expenses were ¥1,143.415 million, up 29.4%, operating income was ¥281.475 million, down 57.3%, ordinary income was ¥388.230 million, down 40.3%, and quarterly net income was ¥299.977 million, down 26.8%.」
While net sales increased 2.6% year on year, operating income, ordinary income and quarterly net income all declined due to higher selling, general and administrative expenses. - FY2024-Q1WorsenedAnnual report
「As a result, for the cumulative first quarter, net sales were ¥1,173.516 million, up 10.8% year on year, gross profit was ¥763.806 million, down 2.0%, selling, general and administrative expenses were ¥557.945 million, up 30.3%, operating income was ¥205.861 million, down 41.4%, ordinary income was ¥208.429 million, down 37.7%, and quarterly net income was ¥143.901 million, down 33.4%.」
While net sales increased 10.8% year on year, selling, general and administrative expenses increased 30.3% due to strategic cost investments and other factors, resulting in declines in operating income, ordinary income and quarterly net income. - FY2023WorsenedAnnual report
「Net sales were ¥4,510.544 million, up 5.5% year on year, operating income was ¥1,221.499 million, down 22.2%, and net income was ¥923.142 million, down 9.3%, achieving revenue growth for the seventh consecutive fiscal year since the company's founding.」
Although the company achieved revenue growth for the seventh consecutive fiscal year since its founding, operating income and net income declined, weakening the results from the previous revenue and earnings growth to revenue growth alone. - FY2023-Q3AdvancedAnnual report
「As a result, for the cumulative third quarter, net sales were ¥3,406.128 million, up 18.6% year on year, gross profit was ¥2,431.314 million, up 19.3%, selling, general and administrative expenses were ¥1,388.100 million, up 26.3%, operating income was ¥1,043.213 million, up 11.1%, ordinary income was ¥1,039.279 million, up 9.8%, quarterly net income was ¥675.138 million, up 14.6%, and the Cell Source Growth Rate (hereinafter, “CSGR”) was 50.7% (net sales growth rate of 18.6% + EBITDA margin of 32.1%).」
For the cumulative third quarter, net sales, operating income, ordinary income and quarterly net income increased year on year. Net sales were ¥3,406.128 million, operating income was ¥1,043.213 million and quarterly net income was ¥675.138 million. - FY2023-Q2AdvancedAnnual report
「As a result, for the cumulative second quarter, net sales were ¥2,170.612 million, up 27.9% year on year, gross profit was ¥1,542.630 million, up 28.9%, selling, general and administrative expenses were ¥883.292 million, up 25.2%, operating income was ¥659.338 million, up 34.4%, ordinary income was ¥650.312 million, up 31.1%, quarterly net income was ¥410.061 million, up 33.0%, and the Cell Source Growth Rate (hereinafter, “CSGR”) was 59.7% (net sales growth rate of 27.9% + EBITDA margin of 31.8%).」
For the cumulative second quarter, net sales were ¥2,170.612 million, operating income was ¥659.338 million and quarterly net income was ¥410.061 million, representing year-on-year revenue and earnings growth. - FY2023-Q1AdvancedAnnual report
「As a result, for the cumulative first quarter, net sales were ¥1,059.530 million, up 29.1% year on year, gross profit was ¥779.462 million, up 34.1%, selling, general and administrative expenses were ¥428.175 million, up 27.1%, operating income was ¥351.287 million, up 43.7%, ordinary income was ¥334.312 million, up 36.5%, quarterly net income was ¥216.044 million, up 38.7%, and the Cell Source Growth Rate (hereinafter, “CSGR”) was 63.7% (net sales growth rate of 29.1% + EBITDA margin of 34.6%).」
In the first quarter, net sales, operating income, ordinary income and quarterly net income increased year on year, and CSGR was 63.7%. - FY2022AdvancedAnnual report
「Net sales were ¥4,273.829 million, up 46.3% year on year, operating income was ¥1,571.052 million, up 58.3%, and net income was ¥1,017.842 million, up 56.3%, achieving revenue and earnings growth for the sixth consecutive fiscal year since the company's founding.」
Net sales, operating income and net income increased, resulting in revenue and earnings growth for the sixth consecutive fiscal year since the company's founding. - FY2022-Q3AdvancedAnnual report
「As a result, for the cumulative third quarter, net sales were ¥2,872.987 million, up 36.5% year on year, gross profit was ¥2,037.486 million, up 36.0%, selling, general and administrative expenses were ¥1,098.721 million, up 34.0%, operating income was ¥938.765 million, up 38.3%, ordinary income was ¥946.646 million, up 36.9%, and quarterly net income was ¥589.126 million, up 37.6%.」
For the cumulative third quarter, net sales were ¥2,872.987 million, operating income was ¥938.765 million, ordinary income was ¥946.646 million and quarterly net income was ¥589.126 million, representing year-on-year revenue and earnings growth. - FY2022-Q2AdvancedAnnual report
「As a result, for the cumulative second quarter, net sales were ¥1,697.020 million, up 26.3% year on year, gross profit was ¥1,196.308 million, up 24.6%, selling, general and administrative expenses were ¥705.557 million, up 31.3%, operating income was ¥490.751 million, up 16.2%, ordinary income was ¥495.959 million, up 13.9%, and quarterly net income was ¥308.390 million, up 14.7%.」
For the cumulative second quarter of the fiscal year ending October 2022, net sales, operating income, ordinary income and quarterly net income increased year on year, resulting in revenue and earnings growth. - FY2022-Q1AdvancedAnnual report
「As a result, for the cumulative first quarter, net sales were ¥820.917 million, up 31.8% year on year, gross profit was ¥581.332 million, up 29.4%, selling, general and administrative expenses were ¥336.955 million, up 25.3%, operating income was ¥244.376 million, up 35.6%, ordinary income was ¥244.938 million, up 35.5%, and quarterly net income was ¥155.766 million, up 37.7%.」
In the first quarter of the fiscal year ending October 2022, net sales were ¥820.917 million, operating income was ¥244.376 million, ordinary income was ¥244.938 million and quarterly net income was ¥155.766 million, representing year-on-year revenue and earnings growth. - FY2021AdvancedAnnual report
「Net sales were ¥2,922.232 million, up 57.5% year on year, operating income was ¥992.441 million, up 138.8%, and net income was ¥651.396 million, up 137.7%, achieving revenue and earnings growth for the fifth consecutive fiscal year since the company's founding.」
Net sales, operating income and net income increased substantially, achieving revenue and earnings growth for the fifth consecutive fiscal year since the company's founding. - FY2021-Q3AdvancedAnnual report
「As a result, for the cumulative third quarter, net sales were ¥2,104.265 million, up 60.4% year on year, gross profit was ¥1,498.393 million, up 70.8%, selling, general and administrative expenses were ¥819.683 million, up 31.2%, operating income was ¥678.710 million, up 168.5%, ordinary income was ¥691.692 million, up 176.7%, and quarterly net income was ¥428.201 million, up 170.4%.」
For the cumulative third quarter of the fiscal year ending October 2021, net sales were ¥2,104.265 million, operating income was ¥678.710 million, ordinary income was ¥691.692 million and quarterly net income was ¥428.201 million, representing substantial year-on-year revenue and earnings growth. - FY2021-Q2AdvancedAnnual report
「Net sales were ¥1,343.125 million, up 51.5% year on year, gross profit was ¥960.025 million, up 60.5%, selling, general and administrative expenses were ¥537.548 million, up 31.0%, operating income was ¥422.476 million, up 124.9%, ordinary income was ¥435.473 million, up 132.8%, and quarterly net income was ¥268.782 million, up 126.9%.」
For the cumulative second quarter of the fiscal year ending October 2021, net sales, operating income, ordinary income and quarterly net income increased year on year. - FY2021-Q1AdvancedAnnual report
「Net sales were ¥622.683 million, up 40.1% year on year, gross profit was ¥449.245 million, up 41.7%, selling, general and administrative expenses were ¥269.024 million, up 39.9%, operating income was ¥180.221 million, up 44.6%, ordinary income was ¥180.813 million, up 46.5%, and quarterly net income was ¥113.112 million, up 45.9%.」
In the first quarter of the fiscal year ending January 2021, net sales, operating income, ordinary income and quarterly net income increased year on year. - FY2020AdvancedAnnual report
「Net sales were ¥1,855.475 million, up 15.1% year on year, gross profit was ¥1,258.956 million, up 9.1%, operating income was ¥415.551 million, up 27.1%, and net income was ¥274.082 million, up 37.3%, achieving revenue and earnings growth for the fourth consecutive fiscal year since the company's founding.」
For the fiscal year ended October 2020, net sales, operating income and net income increased, resulting in revenue and earnings growth for the fourth consecutive fiscal year since the company's founding. - FY2020-Q3AdvancedAnnual report
「For the cumulative third quarter, net sales were ¥1,311.961 million, up 11.9% year on year, gross profit was ¥877.508 million, up 4.0%, selling, general and administrative expenses were ¥624.718 million, up 1.5%, operating income was ¥252.790 million, up 10.9%, ordinary income was ¥250.019 million, up 12.2%, and quarterly net income was ¥158.385 million, up 8.7%.」
Results were added showing year-on-year increases in net sales, operating income, ordinary income and quarterly net income for the cumulative third quarter. - FY2020-Q2AdvancedAnnual report
「For the cumulative second quarter, net sales were ¥886.289 million, gross profit was ¥598.139 million, selling, general and administrative expenses were ¥410.292 million, operating income was ¥187.846 million, ordinary income was ¥187.084 million, and quarterly net income was ¥118.448 million.」
Results for the cumulative second quarter, including net sales, operating income, ordinary income and quarterly net income, were added. Year-on-year comparisons were not made because quarterly financial statements for the same period of the previous year had not been prepared. - FY2020-Q1AdvancedAnnual report
「For the cumulative first quarter, net sales were ¥444.428 million, gross profit was ¥316.979 million, selling, general and administrative expenses were ¥192.354 million, operating income was ¥124.624 million, ordinary income was ¥123.436 million, and quarterly net income was ¥77.529 million.」
Results for the first quarter, including net sales, operating income, ordinary income and quarterly net income, were added. Year-on-year comparisons were not made because financial statements for the same period of the previous year had not been prepared. - FY2019First statedAnnual report
「For the fiscal year, net sales were ¥1,611.587 million, up 32.9% year on year, operating income was ¥326.944 million, up 10.8%, and net income was ¥199.606 million, up 3.2%, achieving revenue and earnings growth for the third consecutive fiscal year since the company's founding.」
Results for the fiscal year ended October 2019 showed growth in sales and earnings, with revenue and earnings increasing for the third consecutive fiscal year.